Skip to main content
  • Impella Connect System App Is Unapproved Medical Software Device Requiring Regulation, FDA Warns Abiomed

    The U.S. Food and Drug Administration (FDA) has warned Abiomed Inc. that its Impella Connect System is a device that is subject to the premarket approval (PMA) process and that the company failed to secure this approval.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details